Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GordonMD Global Investments LP | 4.24M | $37.0M | 6.89% | -- | 2026-06-30 |
| Gilead Sciences, Inc. | 4.13M | $36.0M | 6.70% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.13M | $27.0M | 5.09% | +2.26M | 2026-06-30 |
| Bain Capital Life Sciences Investors, LLC | 2.88M | $25.0M | 4.69% | -225.0K | 2026-06-30 |
| AIGH Capital Management LLC | 2.80M | $24.0M | 4.54% | +795.8K | 2026-06-30 |
| Deerfield Management Company, L.P. | 2.00M | $17.0M | 3.25% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 1.90M | $16.0M | 3.08% | +114.1K | 2026-06-30 |
| Price T Rowe Associates Inc | 1.19M | $10.0M | 1.93% | -369.3K | 2026-06-30 |
| Geode Capital Management, LLC | 1.05M | $9.0M | 1.70% | +625.6K | 2026-06-30 |
| Insight Holdings Group, LLC | 989.1K | $8.0M | 1.61% | -- | 2026-06-30 |
